CE vs SOLV · rev $10.28B vs P/E 9.1, rev $8.25B
Celanese Corporation (CE) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
CE currently screens at market cap $5.92B. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the CE and SOLV stock pages for the full models.
Not investment advice.